Showing results (31-40 of 248) with videos related to

Sort By:
Pageof 25
Journal of Hepatology|April 2, 2013
Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical managementJan Peveling-Oberhag, Luca Arcaini, Martin-Leo Hansmann, et al.
Blood|November 11, 2011
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasmsLuca Arcaini, Silvia Zibellini, Emanuela Boveri, et al.
Leukemia & Lymphoma|April 29, 2020
Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphomaMichele Merli, Irene Defrancesco, Carlo Visco, et al.
Creative Nursing|May 16, 2019
ICA-EMA: A Tool for Assessing Nursing Complexity of Patients With Oncohematologic Disease in an Italian CenterPaolo Iovino, Luigia Scudeller, Virginia Valeria Ferretti, et al.
Haematologica|March 5, 2026
Prognosis in marginal zone lymphoma: a comprehensive reviewAnnalisa Talami, Maria Elena Nizzoli, Emilia Cappello, et al.
Hematology/Oncology Clinics of North America|September 27, 2012
Clinical predictors of outcome in MPNFrancesco Passamonti, Margherita Maffioli, Michele Merli, et al.
Expert Opinion on Investigational Drugs|February 1, 2017
Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphomaAndrea Ferrario, Michele Merli, Claudia Basilico, et al.
American Journal of Hematology|October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana LinfomiGiuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.
The Journal of Infection|December 18, 2019
Hepatitis B virus-associated B-cell non-Hodgkin lymphoma in non-endemic areas in Western Europe: Clinical characteristics and prognosisMarine Lemaitre, Pauline Brice, Marco Frigeni, et al.
Haematologica|November 26, 2013
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana LinfomiMichele Merli, Carlo Visco, Michele Spina, et al.
Pageof 25